Suchergebnisse - "Zeidan, Amer M"

PubPharm (408)

1

Hematocrit control and thrombotic risk in patients with polycythemia vera treated with ruxolitinib in clinical practice

enthalten in: Annals of hematology | 2024

von Chojecki, A. | Boselli, D. | Dortilus, A. | +16

2

Cost-effectiveness of adding quizartinib to induction chemotherapy for patients with FLT3-mutant acute myeloid leukemia

enthalten in: Leukemia & lymphoma | 2024

von Bewersdorf, J. | Patel, K. | Shallis, R. | +9

3

Treatment of Myelodysplastic Syndromes for Older Patients : Current State of Science, Challenges, and Opportunities

enthalten in: Current hematologic malignancy reports | 2024

von Kewan, T. | Stahl, M. | Bewersdorf, J. | +1

4

Hypomethylating agents plus venetoclax compared with intensive induction chemotherapy regimens in molecularly defined secondary AML

enthalten in: Leukemia | 2024

von Shimony, S. | Bewersdorf, J. | Shallis, R. | +15

5

Clinical activity, pharmacokinetics, and pharmacodynamics of oral hypomethylating agents for myelodysplastic syndromes/neoplasms and acute myeloid leukemia : A multidisciplinary review

enthalten in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners | 2024

von Haumschild, R. | Kennerly-Shah, J. | Barbarotta, L. | +1

6

Differentiation syndrome associated with treatment with IDH2 inhibitor enasidenib - pooled analysis from clinical trials

enthalten in: Blood advances | 2024

von Montesinos, P. | Fathi, A. | de Botton, S. | +8

7

Clinical Outcomes in Patients With Refractory Anemia With Excess Blasts (RAEB) Who Receive Hypomethylating Agents (HMAs)

enthalten in: Clinical lymphoma, myeloma & leukemia | 2024

von Zeidan, A. | Mearns, E. | Ng, C. | +8

8

Comparing venetoclax in combination with hypomethylating agents to hypomethylating agent-based therapies for treatment naive TP53-mutated acute myeloid leukemia : results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND)

enthalten in: Blood cancer journal | 2024

von Badar, T. | Nanaa, A. | Atallah, E. | +14

9

Myelodysplastic Syndromes and Myelodysplastic Syndromes/Myeloproliferative Neoplasms : A Real-World Experience From a Developing Country

enthalten in: JCO global oncology | 2024

von Awidi, A. | Alzu'bi, M. | Odeh, N. | +9

10

PD-1H/VISTA mediates immune evasion in acute myeloid leukemia

enthalten in: The Journal of clinical investigation | 2024

von Kim, T. | Han, X. | Hu, Q. | +23

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[41]